Rebeca Font
Biographic Data
| ID | 7682019 |
|---|---|
| NAME | Rebeca Font |
| GIVEN NAMES | Rebeca |
| FAMILY NAME | Font |
| SIGNATURE | FONT R |
| AFFILIATIONS | Institut d'Investigació Biomédica de Bellvitge |
| ORCID | 0009-0005-4121-8457 |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 4 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Validación De Los Conjuntos Mínimos Básicos De Datos Como Fuente De Información Diagnóstica Para La Evaluación De Programas De Cribado De Cáncer De Mama
The Spoc[k] Profile (Screenings/Positives/Colonoscopies/[K]ancer): A Practical Summary of Individual Colorectal Cancer (Crc) Screening Participation and Results for Clinical Care and Programme Improve…
No Excess Mortality up to 10 Years in Early Stages of Breast Cancer in Women Adherent to Oral Endocrine Therapy: A Probabilistic Graphical Modeling Approach
Breast cancer (BC) is globally the most frequent cancer in women. Adherence to endocrine therapy (ET) in hormone-receptor-positive BC patients is active and voluntary for the first five years after diagnosis. This study examines the impact of adherence to ET on 10-year excess mortality (EM) in patients diagnosed with Stages I to III BC (N = 2297). Since sample size is an issue for estimating age- and stage-specific survival indicators, we develop…
Ten-Year Probabilities of Death Due to Cancer and Cardiovascular Disease among Breast Cancer Patients Diagnosed in North-Eastern Spain
Mortality from cardiovascular disease (CVD), second tumours, and other causes is of clinical interest in the long-term follow-up of breast cancer (BC) patients. Using a cohort of BC patients (N = 6758) from the cancer registries of Girona and Tarragona (north-eastern Spain), we studied the 10-year probabilities of death due to BC, other cancers, and CVD according to stage at diagnosis and hormone receptor (HR) status. Among the non-BC causes of d…
No prominent works on this page.
No Excess Mortality up to 10 Years in Early Stages of Breast Cancer in Women Adherent to Oral Endocrine Therapy: A Probabilistic Graphical Modeling Approach
Breast cancer (BC) is globally the most frequent cancer in women. Adherence to endocrine therapy (ET) in hormone-receptor-positive BC patients is active and voluntary for the first five years after diagnosis. This study examines the impact of adherence to ET on 10-year excess mortality (EM) in patients diagnosed with Stages I to III BC (N = 2297). Since sample size is an issue for estimating age- and stage-specific survival indicators, we develop…
Ten-Year Probabilities of Death Due to Cancer and Cardiovascular Disease among Breast Cancer Patients Diagnosed in North-Eastern Spain
Mortality from cardiovascular disease (CVD), second tumours, and other causes is of clinical interest in the long-term follow-up of breast cancer (BC) patients. Using a cohort of BC patients (N = 6758) from the cancer registries of Girona and Tarragona (north-eastern Spain), we studied the 10-year probabilities of death due to BC, other cancers, and CVD according to stage at diagnosis and hormone receptor (HR) status. Among the non-BC causes of d…
Validación De Los Conjuntos Mínimos Básicos De Datos Como Fuente De Información Diagnóstica Para La Evaluación De Programas De Cribado De Cáncer De Mama
The Spoc[k] Profile (Screenings/Positives/Colonoscopies/[K]ancer): A Practical Summary of Individual Colorectal Cancer (Crc) Screening Participation and Results for Clinical Care and Programme Improve…
Breast cancer (2 works) · Breast Cancer Treatment Studies (2 works) · Cancer (2 works) · Cohort (2 works) · Internal Medicine (2 works) · Medicine (2 works) · MEDLINE (2 works) · Oncology (2 works) · Population (2 works) · Advances in Oncology and Radiotherapy (1 works)